In addition, in breast cancer cell lines and primary tumors, the mammalian target of rapamycin (mTOR), a master regulator of metabolism that balances anabolism and catabolism, is targeted by FBXW7 for ubiquitination and degradation [167]. Here, MTOR is linked to breast cancer.